[{"PropertyPlantAndEquipmentNet_0_FY_USD":20325000.0,"ProceedsFromMinorityShareholders_4_FY_USD":24094000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_FY_USD":4000.0,"ValuationAllowanceDeferredTaxAssetChangeInAmount_4_FY_USD":95500000.0,"CurrentFederalTaxExpenseBenefit_4_FY_USD":0.0,"FinanceLeaseInterestPaymentOnLiability_4_FY_USD":9000.0,"NetCashProvidedByUsedInInvestingActivities_4_FY_USD":-52993000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_FY_USD":192000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_FY_USD":3434000.0,"InterestPaidNet_4_FY_USD":15322000.0,"LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_0_FY_USD":2608000.0,"ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_4_FY_USD":-56764000.0,"CommitmentsAndContingencies_0_FY_USD":null,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_4_FY_shares":117995457.0,"GeneralAndAdministrativeExpense_4_FY_USD":145684000.0,"NetIncomeLossAttributableToNoncontrollingInterest_4_FY_USD":-56764000.0,"EffectiveIncomeTaxRateReconciliationOtherAdjustments_4_FY_pure":-0.003,"OperatingLeaseRightOfUseAssetAmortizationExpense_4_FY_USD":3088000.0,"AssetsCurrent_0_FY_USD":642824000.0,"LongTermDebtCurrent_0_FY_USD":1458000.0,"OtherNoncashIncomeExpense_4_FY_USD":-2681000.0,"OperatingLeaseRightOfUseAsset_0_FY_USD":16508000.0,"ShareBasedCompensation_4_FY_USD":58459000.0,"Assets_0_FY_USD":703588000.0,"AvailableForSaleSecuritiesDebtSecurities_0_FY_USD":517448000.0,"CommonStockSharesIssued_0_FY_shares":125264070.0,"UnrecognizedTaxBenefits_0_FY_USD":12524000.0,"FinanceLeaseLiabilityUndiscountedExcessAmount_0_FY_USD":330000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_FY_USD":4291000.0,"TreasuryStockValue_0_FY_USD":75000000.0,"StockIssuedDuringPeriodValueShareBasedCompensation_4_FY_USD":1205000.0,"FinanceLeaseInterestExpense_4_FY_USD":9000.0,"ResearchAndDevelopmentInProcess_4_FY_USD":4727000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_4_FY_shares":29240319.0,"DeferredTaxAssetsOperatingLossCarryforwards_0_FY_USD":191308000.0,"TreasuryStockShares_0_FY_shares":2414681.0,"FinanceLeaseLiabilityPaymentsDueYearTwo_0_FY_USD":420000.0,"FinanceLeaseLiabilityNoncurrent_0_FY_USD":1573000.0,"MarketableSecuritiesCurrent_0_FY_USD":251011000.0,"PreferredStockSharesOutstanding_0_FY_shares":0.0,"DeferredIncomeTaxLiabilities_0_FY_USD":36673000.0,"UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_4_FY_USD":0.0,"MinorityInterestPeriodIncreaseDecrease_4_FY_USD":-1843000.0,"FinanceLeaseLiabilityPaymentsDueYearFive_0_FY_USD":459000.0,"NetCashProvidedByUsedInFinancingActivities_4_FY_USD":447189000.0,"IncreaseDecreaseInEmployeeRelatedLiabilities_4_FY_USD":8589000.0,"TreasuryStockValueAcquiredCostMethod_4_FY_USD":75000000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFive_0_FY_USD":3430000.0,"TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_0_FY_USD":1630000.0,"DeferredTaxLiabilitiesPropertyPlantAndEquipment_0_FY_USD":221000.0,"UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_0_FY_USD":0.0,"CommonStockValue_0_FY_USD":125000.0,"OtherNonoperatingIncomeExpense_4_FY_USD":1634000.0,"ProceedsFromStockPlans_4_FY_USD":1205000.0,"FinanceLeasePrincipalPayments_4_FY_USD":25000.0,"MinorityInterest_0_FY_USD":48350000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_FY_USD":21819000.0,"ResearchAndDevelopmentExpense_4_FY_USD":337047000.0,"IncreaseDecreaseInDueFromRelatedParties_4_FY_USD":-2845000.0,"RestrictedCash_0_FY_USD":2600000.0,"PreferredStockParOrStatedValuePerShare_0_FY_USD":0.001,"DeferredTaxAssetsOther_0_FY_USD":613000.0,"FinanceLeaseLiabilityPaymentsDue_0_FY_USD":2031000.0,"OperatingLeaseLiability_0_FY_USD":18472000.0,"DeferredTaxLiabilities_0_FY_USD":1095000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_4_FY_USD":-62000.0,"DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_0_FY_USD":5707000.0,"FinanceLeaseLiability_0_FY_USD":1701000.0,"Liabilities_0_FY_USD":595702000.0,"AdditionalPaidInCapitalCommonStock_0_FY_USD":1021344000.0,"OperatingLeaseLiabilityNoncurrent_0_FY_USD":14677000.0,"CashAndCashEquivalentsAtCarryingValue_0_FY_USD":356082000.0,"OtherAssetsNoncurrent_0_FY_USD":23931000.0,"IncreaseDecreaseInAccountsPayable_4_FY_USD":-735000.0,"ComprehensiveIncomeNetOfTax_4_FY_USD":-448786000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_4_FY_USD":-448724000.0,"FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_0_FY_USD":238000.0,"EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_4_FY_pure":0.033,"AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtSubsequentAdjustments_4_FY_USD":168078000.0,"FairValueAdjustmentOfWarrants_4_FY_USD":-3338000.0,"ProceedsFromSaleAndMaturityOfMarketableSecurities_4_FY_USD":249137000.0,"AccruedProfessionalFeesCurrent_0_FY_USD":5579000.0,"CommonStockParOrStatedValuePerShare_0_FY_USD":0.001,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_FY_USD":3347000.0,"PaymentsOfDebtIssuanceCosts_4_FY_USD":13039000.0,"AccountsPayableCurrent_0_FY_USD":8945000.0,"LiabilitiesCurrent_0_FY_USD":95648000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_FY_USD":4825000.0,"NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance_4_FY_USD":50828000.0,"NetCashProvidedByUsedInOperatingActivities_4_FY_USD":-399714000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_4_FY_USD":36530000.0,"NonoperatingIncomeExpense_4_FY_USD":-31006000.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_4_FY_USD":714000.0,"FinanceLeaseWeightedAverageDiscountRatePercent_0_FY_pure":0.0662,"EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_4_FY_pure":-0.25,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_FY_USD":196000.0,"DeferredFederalIncomeTaxExpenseBenefit_4_FY_USD":0.0,"PaymentsToAcquireMarketableSecurities_4_FY_USD":287852000.0,"CommonStockSharesOutstanding_0_FY_shares":122849389.0,"ProceedsFromConvertibleDebt_4_FY_USD":550000000.0,"ProceedsFromSaleOfPropertyPlantAndEquipment_4_FY_USD":147000.0,"InterestExpense_4_FY_USD":36655000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_FY_USD":35731000.0,"ProceedsFromStockOptionsExercised_4_FY_USD":12923000.0,"CapitalExpendituresIncurredButNotYetPaid_4_FY_USD":1101000.0,"PreferredStockSharesIssued_0_FY_shares":0.0,"EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent_4_FY_pure":0.01,"AvailableForSaleSecuritiesGrossRealizedGainLossNet_4_FY_USD":0.0,"OperatingLeasePayments_4_FY_USD":4169000.0,"NumberOfOperatingSegments_4_FY_Segment":1.0,"StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_FY_USD":106256000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_FY_USD":358679000.0,"FinanceLeaseLiabilityPaymentsDueYearFour_0_FY_USD":445000.0,"IncreaseDecreaseInOtherOperatingAssets_4_FY_USD":2146000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_FY_pure":0.0624,"EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_4_FY_pure":0.21,"FinanceLeaseLiabilityPaymentsDueYearThree_0_FY_USD":432000.0,"OtherAccruedLiabilitiesCurrent_0_FY_USD":13349000.0,"DeferredTaxLiabilitiesFinancingArrangements_0_FY_USD":32938000.0,"LongTermDebtNoncurrent_0_FY_USD":92421000.0,"UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_4_FY_USD":5144000.0,"DeferredTaxAssetsGross_0_FY_USD":260030000.0,"CurrentForeignTaxExpenseBenefit_4_FY_USD":0.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_4_FY_USD":-5518000.0,"LeaseCost_4_FY_USD":4627000.0,"DeferredTaxAssetsValuationAllowance_0_FY_USD":224452000.0,"AllocatedShareBasedCompensationExpense_4_FY_USD":58459000.0,"PreferredStockSharesAuthorized_0_FY_shares":25000000.0,"EmployeeRelatedLiabilitiesCurrent_0_FY_USD":29682000.0,"LiabilitiesAndStockholdersEquity_0_FY_USD":703588000.0,"OperatingLeaseCost_4_FY_USD":3786000.0,"PreferredStockValue_0_FY_USD":null,"InvestmentIncomeInterest_4_FY_USD":4015000.0,"FinanceLeaseLiabilityPaymentsDueAfterYearFive_0_FY_USD":37000.0,"PaymentsForRepurchaseOfCommonStock_4_FY_USD":75000000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_4_FY_USD":505488000.0,"OperatingIncomeLoss_4_FY_USD":-474482000.0,"ImpairmentOfLongLivedAssetsHeldForUse_4_FY_USD":0.0,"RevenueFromContractWithCustomerExcludingAssessedTax_4_FY_USD":8249000.0,"CommonStockSharesAuthorized_0_FY_shares":500000000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_4_FY_USD":7059000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_FY_USD":3231000.0,"DeferredTaxAssetsEquityMethodInvestments_0_FY_USD":7608000.0,"DeferredTaxAssetsNet_0_FY_USD":35578000.0,"OperatingLeaseLiabilityCurrent_0_FY_USD":3795000.0,"OperatingExpenses_4_FY_USD":482731000.0,"RetainedEarningsAccumulatedDeficit_0_FY_USD":-888755000.0,"DeferredTaxAssetsTaxCreditCarryforwards_0_FY_USD":37964000.0,"VariableLeaseCost_4_FY_USD":832000.0,"DeferredForeignIncomeTaxExpenseBenefit_4_FY_USD":0.0,"DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_0_FY_USD":5471000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_4_FY_USD":505488000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_FY_USD":517256000.0,"AccretionExpense_4_FY_USD":17737000.0,"PaymentsToAcquirePropertyPlantAndEquipment_4_FY_USD":7518000.0,"PaymentsToMinorityShareholders_4_FY_USD":5000000.0,"StockholdersEquity_0_FY_USD":57906000.0,"FinanceLeaseLiabilityCurrent_0_FY_USD":128000.0,"OtherLiabilitiesNoncurrent_0_FY_USD":9520000.0,"ProfitLoss_4_FY_USD":-505488000.0,"EarningsPerShareBasicAndDiluted_4_FY_USD":-3.8,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_4_FY_USD":19595000.0,"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_4_FY_USD":8335000.0,"RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_4_FY_USD":1726000.0,"ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_4_FY_USD":-505550000.0,"Ticker":"BBIO","CIK":"1743881","name":"BRIDGEBIO PHARMA, INC.","OfficialName":"BridgeBio Pharma Inc. Common Stock","form":"10-K","period":"20201231","fy":"2020.0","fp":"FY","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1594164456.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210225"}]